GAN Limited Share Price London S.E.

Equities

GAN

BMG3728V1090

Software

Delayed London S.E. 07:30:00 05/05/2020 BST 5-day change 1st Jan Change
225 GBX -75.35% Intraday chart for GAN Limited -71.15% -69.01%
Sales 2024 * 151M 12B Sales 2025 * 171M 13.64B Capitalization 53.23M 4.24B
Net income 2024 * -19M -1.51B Net income 2025 * -11M -877M EV / Sales 2024 * 0.38 x
Net Debt 2024 * 3.85M 307M Net Debt 2025 * 238K 18.97M EV / Sales 2025 * 0.31 x
P/E ratio 2024 *
-2.79 x
P/E ratio 2025 *
-4.65 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.3%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 73 31/12/13
Director of Finance/CFO 42 31/08/21
Chief Tech/Sci/R&D Officer 43 12/01/22
Members of the board TitleAgeSince
Chief Executive Officer 73 31/12/13
Director/Board Member 53 09/11/22
Chairman 56 30/11/18
More insiders
GAN Limited is a holding company that is a business-to-business (B2B) supplier of enterprise Software-as-a-Service (SaaS) solutions for online casino gaming (iGaming) and online sports betting applications. It is also a business-to-consumer (B2C) developer and operator of an online sports betting and casino platform, which offers individuals located in Northern Europe, Latin America, and Canada access to a digital portal for engaging in sports betting, online casino games and poker. The B2B segment develops, markets, and sells instances of and GameSTACK technology, GAN Sports, and iSight Back Office that incorporates player registration, account funding and back-office accounting and management tools. The B2C segment includes the operations of Coolbet. Its B2B segment features its technology platform, GameSTACK Internet gaming platform. GameSTACK platform and related support services are geared towards casino operators, with an emphasis on land-based commercial and tribal casinos.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
1.18 USD
Average target price
1.97 USD
Spread / Average Target
+66.95%
Consensus